Table 1.
Variables measured in the study.
| Variables | Administration | During hospitalization (Phase 1a) | At hospital discharge (Phase 1b) | 2 months after stroke (Phase 2) | 4 months after stroke (Phase 3) |
|---|---|---|---|---|---|
| Psychiatric symptoms and disorders | |||||
| MINI | Semi-structured interview | X | X | ||
| MADRS | X | X | |||
| HAM-A | X | X | |||
| BDI-II | Self-report questionnaires | X | X | X | |
| HADS | X | X | X | ||
| EMA | Self-report on smartphone app | X | X | X | |
| Coping strategies | |||||
| Brief-COPE | Self-report questionnaires | X | X | X | |
| EMA | Self-report on smartphone app | X | X | X | |
| Quality of life | |||||
| WHOQOL BREF | Self-report questionnaires | X | X | X | |
| Other measures | |||||
| Sociodemographic, medical conditions and treatment, stroke characteristics and functional deficit | Clinician-report and medical file | X | |||
MINI, Mini International Neuropsychiatric Interview; MADRS, Montgomery and Asberg Depression Rating Scale; HAM-A, Hamilton Anxiety rating scale; BDI-II, Beck Depression Inventory; HADS, Hospital Anxiety and Depression Scale; EMA, Ecological Momentary Assessment; Brief-COPE, Coping with Problem Experienced short version; WHOQOL BREF, World Health Organization Quality Of Life short version.